Tomasz Sewastianik

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Signaling Pathway

Multiple Myeloma

Top Venues

Science advances

Blood cancer discovery

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Ting Du, Yan Song, Arghya Ray, Yao Yao, Mehmet K Samur, Chen Shen, Johany Penailillo, Tomasz Sewastianik, Yu-Tzu Tai, Mariateresa Fulciniti, Nikhil C Munshi, Hao Wu, Ruben D Carrasco, Dharminder Chauhan, Kenneth C Anderson, Xueping Wan
Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma. Blood (2023)
Pedro Pires Goulart Guimaraes, Christian G Figueroa-Espada, Rachel S Riley, Ningqiang Gong, Lulu Xue, Tomasz Sewastianik, Peter S Dennis, Claudia Loebel, Amanda Chung, Sarah J Shepherd, Rebecca M Haley, Alex G Hamilton, Rakan El-Mayta, Karin Wang, Robert S Langer, Daniel G Anderson, Ruben D Carrasco, Michael J Mitchell
In vivo bone marrow microenvironment siRNA delivery using lipid-polymer nanoparticles for multiple myeloma therapy. Proceedings of the National Academy of Sciences of the United States of America 120 (25) (2023)
Ting Du, Yan Song, Arghya Ray, Xueping Wan, Yao Yao, Mehmet K Samur, Chen Shen, Johany Penailillo, Tomasz Sewastianik, Yu-Tzu Tai, Mariateresa Fulciniti, Nikhil C Munshi, Hao Wu, Ruben D Carrasco, Dharminder Chauhan, Kenneth C Anderson
Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma. Blood (2023)
Ting Du, Yan Song, Arghya Ray, Xueping Wan, Yao Yao, Mehmet K Samur, Chen Shen, Johany Penailillo, Tomasz Sewastianik, Yu-Tzu Tai, Mariateresa Fulciniti, Nikhil C Munshi, Hao Wu, Ruben D Carrasco, Dharminder Chauhan, Kenneth C Anderson
Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma. Blood (2023)
Elisa Ten Hacken, Tomasz Sewastianik, Shanye Yin, Gabriela Brunsting Hoffmann, Michaela Gruber, M Kendell Clement, Livius Penter, Robert A Redd, Neil Ruthen, Sebastien Hergalant, Alanna Sholokhova, Geoffrey G Fell, Erin M Parry, Julien Broseus, Romain Guieze, Jennifer A Woyach, María Hernández-Sánchez, Kaitlyn Baranowski, Jackson Southard, Heather Joyal, Leah Billington, Fara Faye D Regis, Elizabeth Witten, Mohamed Uduman, Binyamin Asher Knisbacher, Shuqiang Li, Haoxiang Lyu, Tiziana Vaisitti, Silvia Deaglio, Giorgio Ga Inghirami, Pierre Feugier, Stephan Stilgenbauer, Eugen Tausch, Matthew S Davids, Gad A Getz, Kenneth J Livak, Ivana Bozic, Donna S Neuberg, Ruben D Carrasco, Catherine J Wu
In vivo modeling of CLL transformation to Richter's syndrome reveals convergent evolutionary paths and therapeutic vulnerabilities. Blood cancer discovery (2022)
Helen Tanton, Tomasz Sewastianik, Hyuk-Soo Seo, David Remillard, Roodolph St Pierre, Pratyusha Bala, Daulet Aitymbayev, Peter Dennis, Keith Adler, Ezekiel Geffken, Zoe Yeoh, Nicholas Vangos, Filip Garbicz, David A Scott, Nilay S Sethi, James E Bradner, Sirano Dhe-Paganon, Ruben D Carrasco
A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer. Science advances 8 (17) (2022)
Giada Bianchi, Peter G Czarnecki, Matthew Ho, Aldo M Roccaro, Antonio Sacco, Yawara Kawano, Annamaria Gullà, Anil Aktas Samur, Tianzeng Chen, Kenneth Wen, Yu-Tzu Tai, Maria Moscvin, Xinchen Wu, Gulden Camci-Unal, Matteo Claudio Da Via, Niccolo' Bolli, Tomasz Sewastianik, Ruben D Carrasco, Irene M Ghobrial, Kenneth C Anderson
ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment. Blood cancer discovery 2 (4) (2022)
Jiye Liu, Teru Hideshima, Lijie Xing, Su Wang, Wenrong Zhou, Mehmet Kemal Samur, Tomasz Sewastianik, Daisuke Ogiya, Gang An, Shaobing Gao, Li Yang, Tong Ji, Giada Bianchi, Kenneth Wen, Yu-Tzu Tai, Nikhil Munshi, Paul Gerard Richardson, Ruben Carrasco, Yong Cang, Kenneth C Anderson
ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment. Science advances 7 (23) (2021)